- Home
- GGR vs PROK Comparison
GGR vs PROK Comparison
Compare GGR & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- PROK
- Stock Information
- Founded
- GGR 2011
- PROK 2015
- Country
- GGR Taiwan
- PROK United States
- Employees
- GGR N/A
- PROK N/A
- Industry
- GGR Auto Manufacturing
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GGR Consumer Discretionary
- PROK Health Care
- Exchange
- GGR Nasdaq
- PROK Nasdaq
- Market Cap
- GGR 80.6M
- PROK 85.5M
- IPO Year
- GGR N/A
- PROK N/A
- Fundamental
- Price
- GGR $0.38
- PROK $4.74
- Analyst Decision
- GGR Hold
- PROK Buy
- Analyst Count
- GGR 2
- PROK 4
- Target Price
- GGR $0.50
- PROK $5.33
- AVG Volume (30 Days)
- GGR 477.4K
- PROK 33.2M
- Earning Date
- GGR 08-14-2025
- PROK 08-08-2025
- Dividend Yield
- GGR N/A
- PROK N/A
- EPS Growth
- GGR N/A
- PROK N/A
- EPS
- GGR N/A
- PROK N/A
- Revenue
- GGR $304,551,000.00
- PROK $306,000.00
- Revenue This Year
- GGR N/A
- PROK $54.34
- Revenue Next Year
- GGR $5.00
- PROK N/A
- P/E Ratio
- GGR N/A
- PROK N/A
- Revenue Growth
- GGR N/A
- PROK N/A
- 52 Week Low
- GGR $0.19
- PROK $0.46
- 52 Week High
- GGR $1.65
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- GGR 80.44
- PROK 92.14
- Support Level
- GGR $0.24
- PROK $0.54
- Resistance Level
- GGR $0.42
- PROK $7.13
- Average True Range (ATR)
- GGR 0.02
- PROK 0.62
- MACD
- GGR 0.02
- PROK 0.47
- Stochastic Oscillator
- GGR 85.55
- PROK 68.59
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.